The neuroendocrinology of menstrual cycle mood disorders.
Rubinow
D R
DR
Section on Behavioral Endocrinology, National Institute of Mental Health, Bethesda, Maryland 20892-1276, USA.
Schmidt
P J
PJ
D000339:Affect / Q000502:physiology*; D006063:Chorionic Gonadotropin / Q000008:administration & dosage; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology; D005260:Female; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D008183:Luteal Phase; D008598:Menstruation / Q000187:drug effects; D015735:Mifepristone / Q000008:administration & dosage; D010053:Ovary / Q000502:physiology; D010507:Periodicity; D010913:Pituitary-Adrenal System / Q000502:physiology; D011293:Premenstrual Syndrome / Q000503:physiopathology; D013961:Thyroid Gland / Q000502:physiology; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology
D006063:Chorionic Gonadotropin; D015735:Mifepristone; D013973:Thyrotropin-Releasing Hormone; D003346:Corticotropin-Releasing Hormone